Transdiagnostic iCBT for Depression and Anxiety
Efficacy of Transdiagnostic Internet-based CBT for Early Illness Unipolar Depression and Anxiety
1 other identifier
interventional
77
1 country
1
Brief Summary
This 8-week, pilot randomized, controlled trial to evaluate the benefits of transdiagnostic Internet-based CBT (iCBT) in young adults with MDD, SAD, PD or GAD. The investigators hypothesize that patients who receive iCBT will show significant improvement in anxiety symptoms and functioning, compared to a wait-list group. This pilot randomized controlled study will assess the efficacy of transdiagnostic iCBT in 60 young adults.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable major-depressive-disorder
Started Aug 2014
Longer than P75 for not_applicable major-depressive-disorder
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
August 1, 2014
CompletedFirst Submitted
Initial submission to the registry
October 7, 2014
CompletedFirst Posted
Study publicly available on registry
October 17, 2014
CompletedPrimary Completion
Last participant's last visit for primary outcome
August 1, 2018
CompletedStudy Completion
Last participant's last visit for all outcomes
August 1, 2018
CompletedFebruary 15, 2019
February 1, 2019
4 years
October 7, 2014
February 13, 2019
Conditions
Keywords
Outcome Measures
Primary Outcomes (6)
Change in Hamilton Depression Rating Scale (HAM-D) Total Score
Baseline to study endpoint (Week 8)
Change in Hamilton Anxiety Rating Scale (HAM-A) Total Score
Baseline to study endpoint (Week 8)
Change in Quick Inventory of Depressive Symptomatology Self-Report (QIDS-SR) Total Score
Baseline to study endpoint (Week 8)
Change in Liebowitz Social Anxiety Scale (LSAS) Total Score
Baseline to study endpoint (Week 8)
Change in Panic Disorder Severity Scale Total Score
Baseline to study endpoint (Week 8)
Change in Penn State Worry Questionnaire Total Score
Baseline to study endpoint (Week 8)
Secondary Outcomes (3)
Change in Quality of Life Enjoyment and Satisfaction Questionnaire (Q-LES-Q) Total Score
Baseline to study endpoint (Week 8)
Change in Sheehan Disability Scale (SDS) Total Score
Baseline to study endpoint (Week 8)
Change in Clinical Global Impression (CGI)
Baseline to study endpoint (Week 8)
Study Arms (2)
ICBT Group
EXPERIMENTALThe iCBT program consists of weekly online lessons, weekly homework assignments, regular automatic email reminders about lessons and homework, weekly contact via phone or email with a CBT therapist, and access to a large online library of written resources about depression and anxiety and application of CBT skills. The CBT therapist contacts all participants once a week to review lessons, assist patients with treatment difficulties, reinforce progress and encourage continued engagement with the program. Therapist-patient contact is limited to 10 minutes per patient per week.
Waitlist Group
NO INTERVENTIONUpon completion of the 8-week study wait-list period (i.e. their study participation), the opportunity to participate in iCBT, outside the study framework will be provided.
Interventions
The iCBT program consists of weekly online lessons, weekly homework assignments, regular automatic email reminders about lessons and homework, weekly contact via phone or email with a CBT therapist, and access to a large online library of written resources about depression and anxiety and application of CBT skills. The CBT therapist contacts all participants once a week to review lessons, assist patients with treatment difficulties, reinforce progress and encourage continued engagement with the program. Therapist-patient contact is limited to 10 minutes per patient per week.
Eligibility Criteria
You may qualify if:
- Age range (18-29 years).
- Primary diagnosis of MDD, SAD, PD and/or GAD, per the DSM-IV-TR.
- A score ≥17 on the first 17 items of the Hamilton Depression Rating Scale (HAM-D)55
- A score ≥17 on the Hamilton Anxiety Rating Scale (HAM-A)56.
- Score ≥50 on the Leibowitiz Social Anxiety Scale (LSAS),57 ≥10 on the Panic Disorder Severity Scale (PDSS)58 and/or ≥60 the Penn State Worry Questionnaire (PSWQ).59
- Currently unmedicated or on stable and adequate doses of medication for at least 4 weeks.
- Co-morbidities are allowed and will be documented.
You may not qualify if:
- \. Primary diagnosis of any psychotic disorder or any other anxiety disorder (OCD, PTSD).
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Centre for Addiction and Mental Health
Toronto, Ontario, M5T 1R8, Canada
Related Links
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Arun Ravindran, MD, PhD
Centre for Addiction and Mental Health
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Principal Investigator
Study Record Dates
First Submitted
October 7, 2014
First Posted
October 17, 2014
Study Start
August 1, 2014
Primary Completion
August 1, 2018
Study Completion
August 1, 2018
Last Updated
February 15, 2019
Record last verified: 2019-02